Search - tctmd.com

Displaying 561 - 580 of 805

Sort: Relevancy | Date

News Daily News

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Michael O'Riordan

January 17, 2020

Hypertension Starts Years Earlier in Women Than Men, Serial BP Shows

News Daily News

Hypertension Starts Years Earlier in Women Than Men, Serial BP Shows

January 17, 2020

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

News Daily News

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Michael O'Riordan

January 16, 2020

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

Genetics Only Weakly Predicts Midlife BMI for Young Adults

News Daily News

Genetics Only Weakly Predicts Midlife BMI for Young Adults

January 09, 2020

Stiff Legs, Compliant Arteries: How Marathon Training Helps the Heart

News Daily News

Stiff Legs, Compliant Arteries: How Marathon Training Helps the Heart

Michael O'Riordan

January 07, 2020

Survey Reveals Troubling Unawareness of Common MI Symptoms

News Daily News

Survey Reveals Troubling Unawareness of Common MI Symptoms

December 19, 2019

Aspirin Not Protective Against CVD in Black Patients

News Daily News

Aspirin Not Protective Against CVD in Black Patients

December 18, 2019

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

December 10, 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

November 17, 2019

COLCOT Renews Hope for Anti-inflammatory Secondary Prevention

News Conference News AHA 2019

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

November 16, 2019

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

Testosterone Therapy Ups VTE Risk, Even When Indicated

News Daily News

Testosterone Therapy Ups VTE Risk, Even When Indicated

November 12, 2019

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

News Daily News

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Michael O'Riordan

November 05, 2019

Obesity Prevalence Triples in China Over 10-Year Span

News Daily News

Obesity Prevalence Triples in China Over 10-Year Span

Michael O'Riordan

October 28, 2019

New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients

News Daily News

New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients

Michael O'Riordan

October 22, 2019

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

News Daily News

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

October 21, 2019

CMS Cuts to Office-Based Noninvasive Cardiac Tests Are Driving Costs Higher

News Daily News

CMS Cuts to Office-Based Noninvasive Cardiac Tests Are Driving Costs Higher

October 17, 2019

Chronic Stress in African-Americans Linked to Hypertension

News

Chronic Stress in African-Americans Linked to Hypertension

October 16, 2019

Recurrent Events Common Among Young Patients With CAD

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.